期刊文献+

人主动脉硫酸乙酰肝素蛋白聚糖对胎儿主动脉平滑肌细胞c-fos和c-myc基因表达的影响 被引量:1

The Effect Of Human Aortic Heparan Sulfate Proteoglycan on the Expression of c-fos and c-myc Gene in the Cultured Fetal Aortic Smooth Muscle Cells
下载PDF
导出
摘要 本室以往的研究发现硫酸乙酰肝素蛋白聚糖对培养的胎儿主动脉平滑肌细胞的增殖有明显的抑制作用。本实验采用Northernblot的方法观察硫酸乙酰肝素蛋白聚糖对胎儿主动脉平滑肌细胞的c-fos,c-myc原癌基因的表达的影响,发现前者能抑制后者的表达。因此硫酸乙酰肝素蛋白聚糖抑制平滑肌细胞增殖的途径之一可能为抑制原癌基因的表达。 Our laboratory have found that human aortic heparan sulfate proteoglycan(HSPG) can suppress the proliferation of cultured fetal aortic smooth muscle cells(hASMC).In this study Norther blot was used to invetigate the effect of HSPG on the expression of c-fos and c-myc proto-oncogene in hASMC. The results showed that former can suppress both c-fos and c-myc gene. It is concluded that suppression of protooncogene expression may be one of the causes that HSPG suppresses smooth muscle cell proliferation.
出处 《中国动脉硬化杂志》 CAS CSCD 1996年第2期112-114,共3页 Chinese Journal of Arteriosclerosis
关键词 硫酸乙酰肝素 蛋白聚糖 原癌基因 动脉粥样硬化 Heparan sulfate proteoglycan Smooth muscle cell Proto-oncogene
  • 相关文献

同被引文献31

  • 1[1]Cecena FA. Stenting stent: alternative strategy for treating instent restenosis. Cathet Cardiovasc Diagn, 1996,39(4):377~ 382.
  • 2[2]Le- feuver C, Tahlil O, Feldman LJ, et al. Prospects of pre vention of restenosis after coronary angioplasty. Ann Cardiol Angeiol Paris, 1996,45(7) :383~388.
  • 3[3]Goods CM, Al - Shaibi KF, Liu MW. Comparison of aspirinalone versus aspirin plus ticlopidine after coronary artery stent ing. Am J cardiol, 1996,78(9): 1042~1044.
  • 4[4]Fidder GI, Lumley P. Preliminary clinical studies with throm boxane synthase inhibitors and thromboxane receptors blockers.Circulation, 1990,81(1) :69.
  • 5[5]Sheth SB, Colman RW. Platelet camp and cGMP phosphodi esterases. Platelet, 1994,5(1):61.
  • 6[6]Jang IKK, Fuster V. Cardiovascular pharmacology and thera peutics. New York: Churchill Livingastone Press, 1994,551.
  • 7[7]Kimura Y, Tani T, Kanbe T, et al. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arznimittel for schung/Drug Res, 1985:1144~1149.
  • 8[8]Tanaka T, Ishikawa T, Hagiwara M, et al. Effect of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology, 1988: 313 ~ 320.
  • 9[9]Ohashi S, Iwatani Y, Hyakuna Y, et al. Therrnographic evalua tion of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. Arznimittel for schung /Drug Res, 1985:1203~1208.
  • 10[10]Matsumoto Y, Tani T, Watanabe K, et al. Effect of cilosta zol, an antiplatelet drug ,on smooth muscle cell proliferation af ter endothelial denudation in rats. Jpn J Pharmacol, 1992,278: 284.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部